Aziyo Biologics Reports Strong Third Quarter 2022 Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Aziyo Biologics, Inc. (AZYO) Misses Q3 EPS by 6c
November 14, 2022 4:04 PM ESTAziyo Biologics, Inc. (NASDAQ: AZYO) reported Q3 EPS of ($0.73), $0.06 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $5.05 million versus the consensus estimate of $12.38 million.
GUIDANCE:
Aziyo Biologics, Inc. sees FY2022 revenue of $48-50... More
